1
|
Li H, Wang S, Wang G, Zhang Z, Wu X, Zhang
T, Fu B and Chen G: Yes-associated protein expression is a
predictive marker for recurrence of hepatocellular carcinoma after
liver transplantation. Dig Surg. 31:468–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ji X, Zhang Q, Du Y, Liu W, Li Z, Hou X
and Cao G: Somatic mutations, viral integration and epigenetic
modification in the evolution of hepatitis B virus-induced
hepatocellular carcinoma. Curr Genomics. 15:469–480. 2014.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Bahnassy AA, Zekri ARN, El-Bastawisy A,
Fawzy A, Shetta M, Hussein N, Omran D, Ahmed AAS and El-Labbody SS:
Circulating tumor and cancer stem cells in hepatitis C
virus-associated liver disease. World J Gastroenterol.
20:18240–18248. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chen X, Jiang W, Yue C, Zhang W, Tong C,
Dai D, Cheng B, Huang C and Lu L: Heparanase contributes to
trans-endothelial migration of hepatocellular carcinoma cells. J
Cancer. 8:3309–3317. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Gehrmann M, Cervello M, Montalto G,
Cappello F, Gulino A, Knape C, Specht HM and Multhoff G: Heat shock
protein 70 serum levels differ significantly in patients with
chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Front Immunol. 5:3072014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kang GH, Lee BS, Lee ES, Kim SH, Lee HY
and Kang DY: Prognostic significance of p53, mTOR, c-Met, IGF-1R,
and HSP70 overexpression after the resection of hepatocellular
carcinoma. Gut Liver. 8:79–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Tremosini S, Forner A, Boix L, Vilana R,
Bianchi L, Reig M, Rimola J, Rodríguez-Lope C, Ayuso C, Solé M, et
al: Prospective validation of an immunohistochemical panel
(glypican 3, heat shock protein 70 and glutamine synthetase) in
liver biopsies for diagnosis of very early hepatocellular
carcinoma. Gut. 61:1481–1487. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liu K, Zhao X, Gu J, Wu J, Zhang H and Li
Y: Effects of 12C6+ heavy ion beam irradiation on the
p53 signaling pathway in HepG2 liver cancer cells. Acta Biochim
Biophys Sin (Shanghai). 49:989–998. 2017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Liu K, Lee J, Kim JY, Wang L, Tian Y, Chan
ST, Cho C, Machida K, Chen D and Ou JJ: Mitophagy controls the
activities of tumor suppressor p53 to regulate hepatic cancer stem
cells. Mol Cell. 68(281–292): e52017.
|
10
|
Chai Y, Xiaoyu L and Haiyan W: Correlation
between expression levels of PTEN and p53 genes and the clinical
features of HBsAg-positive liver cancer. J BUON. 22:942–946.
2017.PubMed/NCBI
|
11
|
EI-Emshaty HM, Saad EA, Toson EA, Malak
Abdel CA and Gadelhak NA: Apoptosis and cell proliferation:
Correlation with BCL-2 and p53 oncoprotein expression in human
hepatocellular carcinoma. Hepatogastroenterology. 61:1393–1401.
2014.PubMed/NCBI
|
12
|
Meng X, Franklin DA, Dong J and Zhang Y:
MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res.
74:7161–7167. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lagana SM, Salomao M, Bao F, Moreira RK,
Lefkowitch JH and Remotti HE: Utility of an immunohistochemical
panel consisting of glypican-3, heat-shock protein-70, and
glutamine synthetase in the distinction of low-grade hepatocellular
carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol
Morphol. 21:170–176. 2013.PubMed/NCBI
|
14
|
Fu Y, Xu X, Huang D, Cui D, Liu L, Liu J,
He Z, Liu J, Zheng S and Luo Y: Plasma heat shock protein 90alpha
as a biomarker for the diagnosis of liver cancer: An official,
large-scale, and multicenter clinical trial. EBioMedicine.
24:56–63. 2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tawada A, Kanda T and Yokosuka O: Current
and future directions for treating hepatitis B virus infection.
World J Hepatol. 7:1541–1552. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Abdelfattah MR, Abaalkhail F and Al-Manea
H: Misdiagnosed or incidentally detected hepatocellular carcinoma
in explanted livers: Lessons learned. Ann Transplant. 20:366–372.
2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lun-Gen L: Antiviral therapy of liver
cirrhosis related to hepatitis B virus infection. J Clin Transl
Hepatol. 2:197–201. 2014.PubMed/NCBI
|
18
|
Zhang D and Xu A: Application of
dual-source CT perfusion imaging and MRI for the diagnosis of
primary liver cancer. Oncol Lett. 14:5753–5758. 2017.PubMed/NCBI
|
19
|
Moreira AJ, Rodrigues G, Bona S, Cerski
CT, Marroni CA, Mauriz JL, González-Gallego J and Marroni NP:
Oxidative stress and cell damage in a model of precancerous lesions
and advanced hepatocellular carcinoma in rats. Toxicol Rep.
2:333–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wu W, Liu S, Liang Y, Zhou Z, Bian W and
Liu X: Stress hormone cortisol enhances Bcl-2 like-12 expression to
inhibit p53 in hepatocellular carcinoma cells. Dig Dis Sci.
62:3495–3500. 2017. View Article : Google Scholar : PubMed/NCBI
|